A Long-term Follow-up Study of Participants Who Received Delandistrogene Moxeparvovec (SRP-9001) in a Previous Clinical Study (EXPEDITION)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05967351 |
Recruitment Status :
Enrolling by invitation
First Posted : August 1, 2023
Last Update Posted : May 16, 2024
|
Sponsor:
Sarepta Therapeutics, Inc.
Collaborator:
Hoffmann-La Roche
Information provided by (Responsible Party):
Sarepta Therapeutics, Inc.
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Enrolling by invitation |
---|---|
Estimated Primary Completion Date : | November 30, 2030 |
Estimated Study Completion Date : | November 30, 2030 |